baber/WOPTO huggingface dataset:
Patent NZ-555221-A (NZ)
Title: A combination of APETALA1 and SEPALLATA1 for producing seed plants exhibiting modulated reproductive development
Inventor: YANOFSKY MARTIN F
IPC: C12N15/82
Filed: 2002-05-08
Abstract: Disclosed are non-naturally occurring seed plants that exhibit modulated reproductive development and methods of modulating the timing of reproductive development in plants. The plants comprise a first ectopically expressed polynucleotide encoding an APETALA1 gene product at least 70% identical to SEQ ID NO:2, and a second ectopically expressed polynucleotide encoding a SEP1 gene product at least 70% identical to SEQ ID NO:28, wherein the plant is characterized by early reproductive development compared to a plant lacking the first and second ectopically expressed polynucleotides.
Patent NZ-556561-A (NZ)
Title: Adam-9 modulators
Inventor: MATHER JENNIE
IPC: C07K16/00
Filed: 2006-02-02
Abstract: Provided is a purified immunoglobulin produced by hybridoma ATCC No. PTA# 5174, or an antigen-binding fragment thereof that specifically binds to KID24, specifically binds to the same epitope on KID24 as antibody mu-anti-KID24 specifically binds, and has at least one of the following characteristics: a. the ability to bind to KID24 on a cancer cell; b. the ability to bind to a portion of KID24 that is exposed on the surface of a living cancer cell in vitro or in vivo; c. the ability to deliver a therapeutic agent or detectable marker to a cancer cell expressing KID24; and d. the ability to deliver a therapeutic agent or detectable marker into a cancer cell expressing KID24. The antibody is useful in the treatment of various cancers.
Patent NZ-567015-A (NZ)
Title: Des-C,D analogs of 1alpha,25-dihydroxy-19-norvitamin D3
Inventor: DELUCA HECTOR F
IPC: A61K31/045
Filed: 2006-08-30
Abstract: Disclosed is a compound-wherein the compound is a des-C, D analog of 2-methylene-1-alpha,25-dihydroxy-19-norvitamin D3. Also disclosed is a formulation comprising said compound and the use of the said compound in the manufacture of a medicament to treat a biological disorder e.g. cancer.
Patent NZ-567517-A (NZ)
Title: Preparation of canola protein isolate involving isoelectric precipitation
Inventor: SEGALL KEVIN I
IPC: A23L11/00
Filed: 2006-09-21
Abstract: Disclosed herein is a process for preparing a canola protein isolate, which includes: a) extracting a canola oil seed meal to cause solubilisation of canola protein in the canola oil seed meal and to form an aqueous protein solution having a pH of 5 to 6.8; b) separating the aqueous protein solution from residual canola oil seed meal; c) acidifying the aqueous protein solution to a pH of 3 to 4 to isoelectrically precipitate there from a canola protein isolate having a protein content of at least 90 wt% (N x 6.25) and consisting predominantly of 7S canola protein; and d) separating the isoelecrtically precipitate canola protein isolate from supernatant. Also disclosed is an acidified beverage containing a canola protein isolate as prepared by a process as defined above.
Patent NZ-571158-A (NZ)
Title: Use of non-digestible saccharides administered to a pregnant woman for giving an infant the best start after birth
Inventor: BEERMANN CHRISTOPHER
IPC: A23L33/00
Filed: 2007-03-09
Abstract: Disclosed is the use of a water soluble, non-digestible saccharide for the manufacture of a composition for (i) improving the intestinal flora development of an infant after birth; and/or (ii) strengthening the immune system and/or prevention of immune system related disorders of the infant after birth, wherein said composition is for administration to a woman pregnant with the infant; and the use of a water soluble, non-digestible saccharide for the manufacture of a composition for preventing a disorder selected from the group consisting of allergy, eczema, asthma, rhinitis, hayfever, rhinoconjunctivitis, wheezing, intestinal infections, vaginal infections, respiratory infections, diarrhoea, constipation, cramps and intestinal inflammation in an infant after birth, wherein said composition is for administration to a woman pregnant with the infant. Said non-digestible saccharide may be selected from the group consisting of transgalactooligosaccharides, galactooligosaccharides, lacto-N-tetraose (LNT), lacto-N-neotetraose (neoLNT), fucosyl-Iactose, fucosylated LNT and fucosylated neo-LNT, and alpha-galactooligosaccharide.
Patent NZ-582627-A (NZ)
Title: Nebulization of monoclonal antibodies for treating pulmonary diseases
Inventor: WANG YI
IPC: C07K16/18
Filed: 2006-05-10
Abstract: Provided is the use of an antibody that inhibits activation of the complement cascade in the manufacture of a medicament for preventing or treating in a subject a pulmonary condition in which complement is activated, wherein said antibody has an active Fab fragment and a mutated Fc portion, and wherein the mutated Fc portion does not activate complement, wherein the medicament is suitable for co-administration with an additional active agent, and wherein said antibody is specific to C5, C5 convertase, C5a or C5b-9. (61) Addition to 538384
Patent NZ-583179-A (NZ)
Title: CD40 antibody formulation and methods
Inventor: BEDIAN VAHE
IPC: A61K39/395
Filed: 2004-12-09
Abstract: Provided is the use of a CD40 agonist antibody for the manufacture of a medicament for the treatment of cancer in a patient, wherein the medicament is formulated for administration to the patient according to an intermittent dosing regimen of at least two cycles, each cycle comprising (a) a dosing period of 1-5 days wherein the medicament is formulated to provide 0.03 to 3.0 mg/kg/day of the antibody and, thereafter, (b) a resting period from I to 8 weeks, and wherein the antibody is selected from the group consisting of antibodies 3.1.1, 3.l.lH-A78T, 3.1.1H-A78T-V88A-V97A, 3.1.1H-A78T-V88AV97A13. l.lL-L4M-L83V, 7.1.2, 10.8.3, 15.1.1, 21.4.1, 21.2.1, 22.1.1, 22.l.lH-CI09A, 23.5.1, 23.25.1,23.28.1, 23.28.1H-Dl6E, 23.29.1, 24.2.1, 3.l.lL-L4M-L83V, and 23.28.1 L-C92A. (62) Divided Out of 547162
Patent NZ-583213-A (NZ)
Title: System and method for dispensing iced beverages through different sized orifices
Inventor: BAKER BENJAMIN PAUL
IPC: B67D1/08
Filed: 2008-07-09
Abstract: A method and system of providing an iced beverage (40) is disclosed. The iced beverage (40) may be iced beer or iced soft drink. The method includes the steps of dispensing a chilled beverage (10) from a font (18) at a subzero temperature and cooling the font (14, 16) to a temperature cooler than the beverage, but not substantially cooler. The beverage is first dispensed through a smaller orifice at a pre-set flow rate which becomes ice or slush. After a period of time the liquid beverage is dispensed through a larger diameter orifice as a liquid containing ice, typically in the form of flakes, and/or slush, and/or crystals.
Patent NZ-585486-A (NZ)
Title: Load control of heavy rotating machines for soft transitions between selectable rotational speeds
Inventor: SLETTEVOLL HALLVARD
IPC: H02P5/747
Filed: 2008-10-22
Abstract: A system for control of rotational speed and power on a heavy rotating process machine (P) is disclosed. The rotating process machine (P) is connected to at least one motor or generator (M1) through a shaft and arranged to rotate with a rotational speed given by the motor or generator (M1). The shaft connecting the process machine (P) to the motor or generator (M1) constitutes the rotational axis of the processing machine and the rotating process machine (P) has an adjustable a load control (PC). The rotational speed of the motor or generator (M1) is controlled by a control system (C) and the control system (C) also controls the load control (PC) to achieve soft transitions between several selectable rotational speeds. Lower energy consumption is achieved by step-by-step adjustment of the power and rotational speed of the motor or generator (M1) to varying energy requirements.
Patent NZ-585653-A (NZ)
Title: System for combining a plurality of views of real-time streaming interactive video
Inventor: PERLMAN STEPHEN G
IPC: H04N7/173
Filed: 2008-12-04
Abstract: Disclosed is an apparatus to create a plurality of streams of low-latency streaming interactive video. The apparatus comprises a plurality of servers arranged in a parallel processing configuration. Each server produces a stream of low-latency streaming interactive video. There is a unit that combines the plurality of streams into a new stream of low latency streaming interactive video. The unit is also operable to provide a user interface that allows real-time interactive manipulation of the resulting combined streams by a user.
Patent NZ-588518-A (NZ)
Title: Process for filtration of water in a tank including emitting ultrasonic waves in the tank and adding a flocculent agent to the water
Inventor: FISCHMANN TORRES FERNANDO BENJAMIN
IPC: B01D21/01
Filed: 2009-03-11
Abstract: 588518 Disclosed is a process for filtration of water in a tank, where the filtration is performed over a small volume of water and not on the totality of the water from the tank. The process comprises the following steps: (a) emitting ultrasonic waves in the tank; (b) adding a flocculent agent to the water; (c) covering the tank bottom with a suctioning device which suctions a water flow with flocculated particles, discharging to a collecting effluent line; (d) filtering the effluent flow of the suctioning device from said collecting effluent line; and (e) returning the filtered flow to the tank.
Patent NZ-589682-A (NZ)
Title: Apparatus for generating electric power using wind energy where each wind collecting blade has a movable auxilliary plate contained therein
Inventor: CHUNG CHUN-NENG
IPC: F03D1/04
Filed: 2010-12-02
Abstract: An apparatus for generating electric power from wind energy is disclosed. The apparatus comprises: a base; a blade device; at least one blade unit; a generator; and a wind collecting unit mounted on the base. The blade device includes an upright rod extending vertically along a pivot axis and has a lower end disposed pivotally in the base. At least one blade unit has a plurality of upright blades connected directly and fixedly to the upright rod such that the blade device is rotatable relative to the base about the pivot axis so as to convert wind energy into a mechanical rotary power output. Each of the blades of the blade unit have opposite first and second side surfaces, and a plurality of first wind-collecting ribs extend vertically from the first side surface, spaced apart from each other such that a wind-collecting space is defined between any two adjacent ones of the first wind-collecting ribs. The wind collecting ribs have a thickness that increases gradually toward the first side surface where the first side surface of each of the blades of the blade unit face the second side surface of an adjacent one of the blades. The generator is disposed in the base and coupled to the lower end of the upright rod of the blade device to convert the mechanical rotary power output into electric power. The wind-collecting unit is mounted on the base and includes a plurality of upright plates angularly equidistant and disposed around the blade device where any two adjacent ones of the upright plates define an inwardly converging wind-guiding channel therebetween. The upright plates of the wind-collecting unit are non-flat so that wind is guided by the upright plates of the wind-collecting unit to blow onto the first side surfaces of the blades of the blade unit of the blade device via the wind-guiding channels in the wind-collecting unit.
Patent NZ-591039-A (NZ)
Title: Process for catalytically producing ethylene directly from acetic acid in a single reaction zone
Inventor: CHEN LAIYUAN
IPC: C07C1/207
Filed: 2009-07-20
Abstract: Disclosed is a process for selective and direct formation of ethylene from acetic acid comprising: contacting a feed stream containing acetic acid and hydrogen at a temperature in the range of 200 degrees to 375 degrees Celsius in a single reaction zone to form ethylene. The reaction takes place with a hydrogenating catalyst on a zeolite support; with a hydrogenating catalyst chosen from copper supported on iron oxide, copper-aluminium catalyst, cobalt supported on H-ZSM-5, ruthenium-cobalt supported on silica or cobalt supported on carbon; or with a hydrogenating catalyst and a dehydrating catalyst. The reaction bed may also optionally include a dehydrating catalyst or a cracking catalyst.
Patent NZ-592999-A (NZ)
Title: Spiroheterocyclic n-oxypiperidines as pesticides
Inventor: CASSAYRE JEROME YVES
IPC: A01N43/90
Filed: 2009-12-09
Abstract: Disclosed herein are N-alkyl amide substituted spiroheterocyclic pyrrolidine dione compounds of general formula (I), wherein the substituents are as defined within the specification, processes for preparing them, pesticidal, in particular insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising them and to methods of using them to combat and control pests such as insect, acarine, mollusc and nematode pests.
Patent NZ-593929-A (NZ)
Title: Transparent, colorless infrared radiation absorbing compositions comprising non-stoichiometric tungsten oxide nanoparticles
Inventor: GAUDET GREGORY T
IPC: C08K3/22
Filed: 2010-01-20
Abstract: 593929 Disclosed is a composition comprising: (a) a binder comprising a thermosetting composition and/or a thermoplastic composition comprising polyesters, poly(ethylene terephthalate), polypropylenes, polyamides, polyolefins, polystyrenes, vinyl polymers, acrylic polymers or copolymers or blends thereof; and (b) no more than 500 parts per million, based on the total weight of the composition, of non-stoichiometric tungsten oxide particles having an average primary particle size of no more than 300 nanometers dispersed in the binder. Also disclosed is film on a substrate, the film comprising: (a) a binder; and (b) no more than 500 parts per million, based on the total weight of the film, of generally spherical non-stoichiometric tungsten oxide particles having an average primary particle size of no more than 300 nanometers dispersed in the binder, wherein the film is transparent and colourless and has a surface resistance of greater than 1.0 x 1010 Ω/square.
Patent NZ-594767-A (NZ)
Title: Indole derivatives as crth2 receptor antagonists
Inventor: BERTHELETTE CARL
IPC: A61K31/405
Filed: 2010-02-19
Abstract: 594767 Disclosed herein is a compound of formula I, wherein the variables are defined in the specification, and the use thereof in the treatment of asthma. Specific embodiments of the compound include: [7-(4-benzyl-[1,2,3]triazol-1-yl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-acetic acid, { 7-[4-(4-methoxy-phenyl)-[1,2,3]triazol-1-yl]-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl} -acetic acid, 4-[3-(10-carboxymethyl-6,7,8,9-tetrahydropyrido[1,2-a]indol-7-yl)-3H-[1,2,3]triazol-4-yl]piperidine-1-carboxylic acid tert-butyl ester, and ((R)-7-{ 5-[1-(4-fluorophenyl)-1-hydroxyethyl]-[1,2,3]-triazol-1-yl} -6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl)-acetic acid.
Patent NZ-597911-A (NZ)
Title: Pteridines and their use as agrochemicals
Inventor: BREWSTER WILLIAM
IPC: A01N43/90
Filed: 2009-08-31
Abstract: The present disclosure relates to pteridine compounds and their use as agrochemicals and animal health products. Compounds of the disclosure include: 4-{ 2-[4-(4-Trifluoromethylpyridin-2-yloxy)-phenyl]-ethoxy} -pteridine, Acetic acid 5-[2-(pteridin-4-ylamino)-ethyl]-2-(4-trifluoromethylpyridin-2-yloxy)-phenyl ester, (2- { 4-[2-(4-Benzyloxy-phenyl)-ethoxyl-phenyl} -ethyl)-pteridin-4-yl-amine, and [2-(4-Hydroxyphenyl)-ethyl]-pteridin-4-yl-carbamic acid tert-butyl ester{ 2-[4-{ tert-Butyldimethylsilanyloxy)-phenyl]-ethyl} -pteridin-4-yl-carbamic acid tert-butyl ester.
Patent NZ-598113-A (NZ)
Title: Setting back-up support rate for a ventilator
Inventor: BASSIN DAVID JOHN
IPC: A61M16/00
Filed: 2004-03-05
Abstract: A controller for a positive airway pressure ventilator includes a processor and is coupled to a sensor to detect spontaneous breathing of the patient and a ventilation generation device and controls the ventilation of the patient so that: a first machine breath is initiated as a function of an initial timing threshold when a spontaneous breath is not detected (20, 24, 26), the initial timing threshold is modified 28 if a continued absence of a spontaneous breath is detected, and a second machine breath is initiated as a function of the modified timing threshold during the continued absence of the detection of a spontaneous breath.
Patent NZ-611208-A (NZ)
Title: Effervescent composition for improved carbon dioxide generation in insect monitor devices
Inventor: VARANYAK LINDA
IPC: C01B32/50
Filed: 2011-10-05
Abstract: 611208 The disclosure relates a chemical composition for generating carbon dioxide for use with an insect monitor and/or capture device comprising: an effervescent agent which is an alkaline carbonate salt, a solid acid, a deliquescent agent which is magnesium chloride hexahydrate and optionally an anticlumping agent. The solid acid is selected from the group consisting of citric acid monohydrate, maleic acid, malic acid, oxalic acid, malonic acid, tartaric acid, aspartic acid, fumaric acid, isophthalic acid, phthalic acid, terephthalic acid, salicylic acid, gentisic acid, gallic acid, mandelic acid, tropic acid, cinnamic acid, benzoic acid, nicotinic acid, phenylacetic acid, sorbic acid, 2-pyrrolidone-5-carboxylic acid, trimellitic acid, ptoluene sulfonic acid and benzene sulfonic acid. The anti-clumping agent is selected from the group consisting of fumed silica, amorphous silica, kaolin clay and mixtures thereof. molar ratio of effervescent agent to solid acid to deliquescent agent is from 159:52:1 to 10:3:1. The effervescent agent may comprise sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, ammonium carbonate, ammonium bicarbonate and calcium carbonate.
Patent NZ-612483-A (NZ)
Title: Drug selection for malignant cancer therapy using antibody-based arrays
Inventor: SINGH SHARAT
IPC: G01N33/574
Filed: 2011-12-21
Abstract: Disclosed is a method for therapy selection for a subject with a malignant cancer involving aberrant c-Met signaling, the method comprising: (a) detecting and/or quantifying the expression level and/or activation level of cMet protein in a sample taken from the subject; (b) detecting and/or quantifying the expression level and/or activation level of HER3 protein in the sample; (c) comparing the expression level and/or activation level of cMet protein and/or HER3 protein in the sample to (i) the expression level and/or activation level of a control protein and/or (ii) the expression level and/or activation level of cMet protein and/or HER3 protein in a control sample; and (d) determining whether to administer a cMet inhibitor alone or a cMet inhibitor in combination with a pathway-directed therapy based upon a difference between the expression level and/or activation level of cMet protein and/or HER3 protein in the sample compared to the control protein and/or control sample, wherein the cMet inhibitor should be administered alone when the expression level and/or activation level of cMet protein and/or HER3 protein in the sample is determined to range from medium to high compared to the control protein and/or control sample.
Patent NZ-619272-A (NZ)
Title: A wood processor and processing method
Inventor: WILLIAM RAUDSEPP
IPC: F26B3/04
Filed: 2013-12-19
Abstract: A single-pass solid wood heating and/or drying kiln (1) for heating and/or drying a charge (6) of solid wood. The kiln (1) comprising: a chamber (2) comprising a pathway along which the charge can be moved through the chamber; the chamber further comprising a central drying area (4), a pre-heating area (3) at a first end of the chamber and a conditioning area (5) at a second end of the chamber, wherein the central drying area (4) is in fluid communication with the pre-heating (3) and conditioning (5) areas via a fluid flow path, the chamber (2) being arranged such that thermal energy is recovered from the central drying area and redistributed to the pre-heating and/or conditioning areas. Fans (7) may be provided to circulate the air in a direction transverse to the pathway along which the charge (6) travels. An electronic controller may be used to monitor the drying process and control the charge speed, and/or the proportion of air transferred from the central drying area to each of the pre-heating or conditioning areas.
Patent NZ-620265-A (NZ)
Title: Leaf spring and compressor with leaf spring
Inventor: VOLLRATH INGWALD
IPC: F16F1/32
Filed: 2012-06-21
Abstract: Reciprocating compressor provided with leaf springs 1 comprising at least one spacer 3 disposed between at least a pair of flat springs 2, each flat spring 2 being comprised by at least one outer ring 21, at least one inner ring 22 and at least one connection extension 23 capable of connecting an outer ring 21 to an inner ring 22. The outer ring 21 and the inner ring 22 are concentric to each other. The leaf springs comprise at least one section of physical contact between at least a pair of outer rings defined by at least one spacer, at least one section of physical contact between at least a pair of inner rings defined by at least one spacer, and at least one section free of physical contact between at least two connection extensions adjacently arranged. Each spacer 3 comprises an inner spacer which has analogous diameter to the diameter of the inner ring and an outer spacer which has analogous diameter to the diameter of the outer ring.
Patent NZ-621364-A (NZ)
Title: A method of animal processing
Inventor: JAMES HENRY RILEY
IPC: F25D17/02
Filed: 2014-02-18
Abstract: A method of processing animal carcasses to minimise bacterial contamination is disclosed. One of the biggest problems in animal processing is the introduction of spoilage and pathogenic bacteria to the carcass during processing. This is minimised by the application of the disclosed method. The method includes removing substantially all the blood from the animal carcass, then refrigerating or freezing the animal carcasses prior to hide removal and evisceration. The carcasses are refrigerated using internal and/or external application of a salt brine solution of between 10°C and -51°C to rapidly cool the carcass, further reducing the possibility of bacterial growth. The stomach and/or colon may evacuated and flushed clean using fluid introduced and removed through the oesophagus before refrigeration. Additionally an oxygen barrier such as starch and/or methylcellulose applied to the stomach and/or colon cavity wall to minimizing metmyoglobin formation in intra-abdominal muscles/organs and consequently maintaining acceptable meat quality.
Patent NZ-623909-A (NZ)
Title: Threads of cross-linked hyaluronic acid and methods of use thereof
Inventor: FERMANIAN SARA
IPC: D02G3/44
Filed: 2012-10-10
Abstract: Disclosed a hyaluronic acid threads cross-linked with butanediol diglycidyl ether (BDDE) with ultimate tensile strength of 2-20 kpsi and a failure load of 0.3-1.3 pounds. Also disclosed are methods of making the thread and the use of the thread in aesthetic applications (e.g., facial contouring, soft tissue augmentation products), surgery (e.g., sutures), drug delivery, negative pressure wound therapy, and moist wound dressing. In a particular embodiment, an aesthetic application relates to the treatment of wrinkles by threading into skin or subcutaneous space adjacent or under the wrinkle.